The human monoclonal antibody golimumab (Symponi) preserved endogenous insulin secretion in sufferers with contemporary-onset form 1 diabetes and diminished their exogenous insulin requirements at 1…
The human monoclonal antibody golimumab (Symponi) preserved endogenous insulin secretion in sufferers with contemporary-onset form 1 diabetes and diminished their exogenous insulin requirements at 1…